NDUFAF2P1

Across TCGA pan-cancer cohorts, NDUFAF2P1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated NDUFAF2P1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher NDUFAF2P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NDUFAF2P1 expression acts as an unfavorable survival marker, although some lineages such as LGG and PRAD show a favorable association.

LIHC, LUAD, and KICH are the cancer types where NDUFAF2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.569	0.807	<.001	91	view →
LUAD	OS	Median	All	0.291	0.456	<.001	90	view →
KICH	DFS	Median	III,IV	0.240	1.000	.001	84	view →
UCEC	DFS	Quartile	All	0.639	0.804	<.001	66	view →
KIRP	OS	Tertile	All	0.873	0.975	<.001	64	view →
HNSC	OS	Quartile	III,IV	0.657	0.825	.002	32	view →
BLCA	DFS	Median	All	0.483	0.695	.002	23	view →
UVM	DFS	Median	III,IV	0.264	0.628	.006	23	view →
MESO	OS	Median	All	0.289	0.493	.002	22	view →
LGG	DFS	Tertile	All	0.463	0.273	<.001	19	view →
OV	DFS	Tertile	II,III,IV	0.499	0.585	.020	16	view →
LUSC	OS	Tertile	III,IV	0.336	0.693	.006	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

NDUFAF2P1–LIHC (OS)

Open the LIHC breakdown →